<!DOCTYPE html>
<html lang="zh-cn">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Official Site for KOKOWA</title>
    <meta name="keywords" content="癌症,疫苗,WT1,日本,诺贝尔"/>
    <meta name="description" content="我们的WT1癌症疫苗,来自日本诺贝尔医学奖获得者。"/>
    <meta name="applicable-device" content="pc,mobile">
    <link href="css/bootstrap.css" rel="stylesheet">
    <link href="css/bxslider.css" rel="stylesheet">
    <link href="css/style.css" rel="stylesheet">
    <link href="css/detailGlide.css" rel="stylesheet">

    <script src="js/jquery.min.js"></script>
    <script src="js/bxslider.min.js"></script>
    <script src="js/common.js"></script>
    <script src="js/bootstrap.js"></script>
    <!--[if lt IE 9]>
    <script src="js/html5shiv.min.js"></script>
    <script src="js/respond.min.js"></script>
    <![endif]-->
</head>
<body>

<header>
    <div class="topBox">
        <div class="borderBottom">
            <div class="container">
                <div class="row">
                    <div class="welcomeBox">KOKOWA<sup>®</sup></div>

                    <div class="languageBox">
                        <a href="index-cn.html" class="zh">中文版</a>                         <a href="index-en.html" class="en">English</a>                         <a href="index-jp.html" class="jp">日本語</a>                     </div>
                    <!--div class="topContactBox">
                        <img src="images/tel.png" />
                        <a>400-400-400XX</a>
                        <img src="images/mail.png" />
                        <a>mxiangcai@163.com</a>
                    </div-->
                </div>
            </div>
        </div>

    </div>

    <!-- Fixed navbar -->
    <nav class="navbar navbar-default navbar-fixed-top">
        <div class="container">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar"
                        aria-expanded="false" aria-controls="navbar">
                    <span class="sr-only">Toggle navigation</span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
                <a href="index-cn.html"><img src="images/logo1.png" class="logo" alt="欢迎光临~"/></a>

            </div>
            <div id="navbar" class="navbar-collapse collapse">
                <ul class="nav navbar-nav navbar-nav-c">
                    <li class="dropdown">
                        <a href="javascript:;">关于WT1</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="aboutWT1-cn.html">什么是WT1?</a></li>
                            <li><a href="./lorand.html">关于癌症治疗及免疫细胞疗法</a></li>
                            <li><a href="javascript:;">与WT1相关的癌症</a></li>
                        </ul>
                    </li>

                    <li class="dropdown">
                        <a href="javascript:;">关于KOKOWA<sup>®</sup>癌症疫苗</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="kokowa-cn.html">什么是KOKOWA<sup>®</sup>疫苗</a></li>
                            <li><a href="lipol-chl.html">KOKOWA<sup>®</sup>疫苗产品说明</a></li>
                        </ul>
                    </li>
                    <li class="dropdown">
                        <a href="javascript:;">我们该做些什么</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="foundation.html">咨询您的保健医生</a></li>
                        </ul>
                    </li>
                    <li class="dropdown">
                        <a href="javascript:;">查询和支持</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="students.html">健康计划</a></li>
                            <li><a href="contact.html">援助计划</a></li>
                            <li><a href="contact.html">学术论坛</a></li>
                        </ul>
                    </li>

                </ul>
                -
            </div><!--/.nav-collapse -->
        </div>
    </nav>
</header>

<!-- bxslider -->
<div class="flash">
    <img src="images/kokowa-wt1-1.png" alt=""/>
</div>



<!--div class="page_bg" style="background: url(images/smal-banner-jp.png) center top no-repeat;">
</div-->

<div class="container threeImgBox">
    <div class="row">
        <div class="index_wt1">
            <h2>WT1疫苗适应的癌症及临床案例</h2>
            <span>WT1疫苗适应的癌症及临床案例。WT1的一段简要说明。</span>
        </div>

    </div>
</div>


<div class="container">
    <div class="row">

        <!-- right -->
        <div class="col-xs-12 col-sm-8 col-md-9" style="float:right">
            <div class="list_box">
                <h2 class="left_h2">WT1疫苗的一些临床案例</h2>
                <div class="contents">
                    <p  class="contents_title">1.多发性胶质母细胞瘤</p>
                    <p>
                        WT1疫苗用于23例HLA-A*2404阳性的复发性多发性胶质母细胞瘤患者，这些患者对标准治疗方法已经有耐药性(77)。接受WT1疫苗注射唯一的副作用是部位的局部红斑。根据RECIST标准，临床反应2例为部分反应(图5)，10例为稳定疾病(SD)，
                        9例为进展性疾病。总有效率9.5%，疾病控制率57.1%。中位无进展生存(PFS)时间和6个月PFS发生率分别为20.0周和33.3%。对于两名SD患者，长期SD分别超过236周和184周，副作用仅在WT1疫苗注射部位出现皮肤红斑。
                    </p>
                    <div style="width:50%;border:3px solid #eee;">
                        <image src="./images/p3.png" class="contents_image"/>
                        <p class="contents_imageNote">图5。复发性多发性胶质母细胞瘤的临床表现。多发性胶质母细胞瘤患者(33岁/男，对原标准治疗耐药) 复发时接种WT1(改良WT1肽，3.0 mg/体，每周一次) ，12次后肿瘤尺寸减少50%</p>
                    </div>

                    <p>2.多发性骨髓瘤
                    </p>
                    <p>
                        骨髓瘤细胞对wt1特异性CTLs介导的颗粒胞吐途径高度敏感(79)。一位HLAA* 242
                        -阳性晚期耐药多发性骨髓瘤患者接受WT1疫苗治疗(图6和图7)(80)。接种WT1疫苗后，骨髓骨髓瘤细胞由85%下降至25%，尿中M蛋白含量由3.6 g/d下降至0.6
                        g/d。骨CT图显示骨病损的改善，特别是肋骨，因此临床反应被评估为最低限度(EGBMT标准)。
                    </p>
                    <image src="./images/p4.png"/>
                    图6。多发性骨髓瘤的临床病程。本例Bence-Jones型多发性骨髓瘤患者(57岁/女)复发后接种WT1疫苗，骨髓细胞和尿中M蛋白的骨髓瘤细胞逐渐减少。（BM,骨髓。）
                    <image src="./images/p5.png"/>
                    图7。改善骨髓瘤对骨的病损。同一例多发性骨髓瘤患者的骨闪烁图显示，接种WT1疫苗可改善骨组织病变，尤其是肋骨。
                    <br/>


                    <p>3.肺癌
                    </p>
                    <p>
                        Tsuboi教授等(74)报道，两例晚期肺癌患者每隔2周接种0.3 mg HLA-A*2402-restricted WT1 peptide，导致肿瘤标志物如绒毛膜胚胎抗原和肿瘤大小减少。
                        Oji教授等(90)分析了WT1免疫球蛋白抗体对非小细胞肺癌(NSCLC) I-III期患者作用，报道表明WT1-specific免疫对延长肺癌患者生存期有重要作用(图9)。

                    </p>
                    <image src="./images/p6.png"/>
                    图9。明显有WT1抗体肺癌患者生存期长于无抗体患者。WT1 IgG免疫在手术前进行。


                    <p>4.慢性粒细胞性白血病
                    </p>
                    <p>
                        MDS是一种干细胞白血病，对WT1肽疫苗接种非常敏感，因此，由于表达WT1的转化白血病造血细胞产生的白细胞迅速减少，所以通常剂量的WT1肽疫苗接种被证明是危险的(72)。因此，2005年开始了新的一期研究，WT1肽的剂量从5
                        mg/体开始，最高达到50 - 15 mg/体。一名57岁的慢性粒细胞白血病男性患者，每两周接种一次非常低剂量的WT1修饰肽5
                        mg/体(图8)(86)。接种WT1肽后，白细胞和单核细胞计数(分别为13780和1930/mL)随着WT1特异性ctl的增加逐渐下降到正常范围。本病例首次证明，接种WT1肽5
                        mg/体即可诱导WT1特异性免疫应答并产生临床效果。
                    </p>
                    <image src="./images/p7.png"/>
                    图8。MDS患者的临床病程。MDS(慢性粒细胞白血病)患者(62岁/男)每隔两周接种非常低剂量的WT1肽(5 mg/次)，指标下降


                    <p>5.乳腺癌
                    </p>
                    <p>
                        Gillmore等(84)分析了5例I/II期乳腺癌hla -
                        a2阳性患者的配对肿瘤引流淋巴结和外周血样本，以量化wt1特异性ctl。WT1四聚体结合T细胞从所有淋巴结样本中扩增出来，但没有相应的外周血样本。这一发现表明wt1特异性ctl可以从乳腺癌患者肿瘤引流淋巴结向外扩张，并发挥肽特异性效应。
                        Oka等(72)报道两例晚期乳腺癌患者分别用0.3 mg改良WT1肽或1.0
                        mg天然WT1肽治疗，均显示转移瘤消退。WT1疫苗接种前，由于结肠转移性肿瘤，后者的病情进展为肠梗阻。第二次接种WT1疫苗后，计算机断层扫描显示结肠管壁增厚明显改善，食欲改善，患者接种WT1疫苗后存活3年1个月
                    </p>

                    <div>
                        <br/>
                    </div>
                </div>
            </div>
        </div>

        <!-- left -->
        <div class="col-xs-12 col-sm-4 col-md-3">

            <div class="left_nav" id="categories">
                <h2 class="left_h2">栏目导航</h2>
                <ul class="left_nav_ul" id="firstpane">
                    <li>
                        <a class="biglink" href="aboutWT1-cn.html">什么是WT1?</a><span class="menu_head">+</span>
                        <ul class="left_snav_ul menu_body">
                            <li><a href="javascript:;">1.WILMS’ TUMOR GENE (WT1)</a></li>
                            <li><a href="javascript:;">2.WT1在血液肿瘤和实体肿瘤的高表达</a></li>
                            <li><a href="javascript:;">3.WT1作为肿瘤抑制抗原</a></li>
                        </ul>
                    </li>
                    <li>
                        <a class="biglink" href="vaccineAdaptedCancer-cn.html">WT1疫苗适应的癌症及临床案例</a><span
                            class="menu_head">+</span>
                        <ul class="left_snav_ul menu_body">
                                <li><a href="javascript:;">部门新闻</a></li>
                        </ul>
                    </li>
                    <li>
                        <a class="biglink" href="principleOfWT1-cn.html">WT1作为肿瘤抑制抗原的原理</a><span
                            class="menu_head">+</span>
                        <ul class="left_snav_ul menu_body">
                            <li><a href="javascript:;">部门新闻</a></li>
                        </ul>
                    </li>
                </ul>
            </div>


            <!--form id="searchform" method="get" action="/T06/search/index/g/c.html">
<div class="input-group search_group">
  <input type="text" name="name" class="form-control input-sm" placeholder="论文及研究成果搜索">
  <span class="input-group-btn">
      <span id="submit_search" onclick="searchform.submit();" title="论文及研究成果搜索" class="glyphicon glyphicon-search btn-lg" aria-hidden="true"></span>
  </span>
</div>
</form-->

            <!--<div class="left_news">-->
            <!--<h2 class="left_h2">研究方向</h2>-->
            <!--<ul class="index_news">-->
            <!--<li><a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand" title="放射性去毒内毒素(托列宁 Tolerin)">放射性去毒内毒素(托列宁 Tolerin)d</a><span class='news_time'>2013-09-28</span></li>-->
            <!--</ul>-->
            <!--</div>-->

            <div class="left_news">
                <h2 class="left_h2">相关研究和论文</h2>
                <ul class="index_news">
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            1. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome
                            11 Wilms tumor locus.
                        </a>
                        <span class='news_time'> Cell 1990;60:509–20.</span>
                        <span class='news_time'>Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            2. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome
                            jumping.
                        </a>
                        <span class='news_time'>Nature 1990;343:774– 8.</span>
                        <span class='news_time'>Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. </span>
                    </li>
                    <li>
                        <a href="https://link.springer.com/article/10.1007/BF02981935"
                           title="Wilms’ tumor gene WT1: its oncogenic function and clinical application.">
                            3. Wilms’ tumor gene WT1: its oncogenic function and clinical application.
                        </a>
                        <span class='news_time'>Int J Hematol 2001;73:177– 87.</span>
                        <span class='news_time'>Sugiyama H. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            4. Isolation, characterization, and expression of the murine Wilms tumor gene (WT1) during
                            kidney development.
                        </a>
                        <span class='news_time'>Mol Cell Biol 1991;11:1707– 12.</span>
                        <span class='news_time'>Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            5. The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a
                            human mesothelioma.
                        </a>
                        <span class='news_time'>Nature Genet 1993;4:415–20.</span>
                        <span class='news_time'>Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            6. Multiple roles for the Wilms’ tumor suppressor, WT1.
                        </a>
                        <span class='news_time'>Cancer Res 1999;59(Suppl 7):1747– 1750s; discussion 1751s.</span>
                        <span class='news_time'>Davies R, Moore A, Schedl A, Bratt E, Miyahawa K, Ladomery M, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            7. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal
                            gland and throughout nephrogenesis.
                        </a>
                        <span class='news_time'>Development 1999;126:1845–57.</span>
                        <span class='news_time'>Moore AW, Mclnnes L, Kreidberg J, Hastie ND, Schedl A.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            8. Expression of the Wilms tumor gene (WT1) in human leukemias.
                        </a>
                        <span class='news_time'>Leukemia 1992;6:405 –9.</span>
                        <span class='news_time'>Miwa H, Beran M, Aunders GF.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            9. Expression of the Candidate Wilms tumor gene, WT1, in human leukemia cells.
                        </a>
                        <span class='news_time'>Leukemia 1993;7:970 –7.</span>
                        <span class='news_time'>Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            10. WT1 as new prognostic factor a new marker for the detection of minimal residual disease
                            in acute leukemia.
                        </a>
                        <span class='news_time'>Blood 1994;84:3071–9.</span>
                        <span class='news_time'>Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            11. High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated
                            with a worse long-term outcome.
                        </a>
                        <span class='news_time'>Blood 1997;90:1217– 25.</span>
                        <span class='news_time'>Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            12. The expression of the Wilms tumor gene in acute myelocytic leukemias as a possible
                            marker for leukemic blast cells.
                        </a>
                        <span class='news_time'>Leukemia 1994;8:2138–43.</span>
                        <span class='news_time'>Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            13. Presence of Wilms tumor gene (wt1) transcripts and the WT1 nuclear protein in the
                            majority of human acute leukemias.
                        </a>
                        <span class='news_time'>Leukemia 1995;9:1060–7.</span>
                        <span class='news_time'>Menssen HD, Renkl H-J, Rodeck U, Maurer J, Notter M, Schwartz S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            14. Detection by monoclonal antibodies of the Wilms’ tumor (WT1) nuclear protein in patients
                            with acute leukemia.
                        </a>
                        <span class='news_time'>Int J Cancer 1997;70:518–23.</span>
                        <span class='news_time'>Menssen HD, Renkl HJ, Rodeck U, Kari C, Schwartz S, Thiel E.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            15. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful
                            tool for monitoring minimal residual disease in acute leukemia patients.
                        </a>
                        <span class='news_time'>Leukemia 2002;16:2115– 21.</span>
                        <span class='news_time'>Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            16. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase
                            chain reaction for Wilms tumor gene (WT1).
                        </a>
                        <span class='news_time'>Int J Hematol 2003;78:349– 56.</span>
                        <span class='news_time'>Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            17. The usefulness of monitoring WT1 gene transcripts for the prediction and management of
                            relapse following allogeneic stem cell transplantation in acute type leukemia.
                        </a>
                        <span class='news_time'>Blood 2003;101:1698–704.</span>
                        <span class='news_time'>Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            18. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia
                            for the development of specific immunotherapies.
                        </a>
                        <span class='news_time'>Int J Cancer 2004;108:704– 11.</span>
                        <span class='news_time'>Greiner J, Ringhoffer M, Taniguchi M, Li L, Schmitt A, Shiku H, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            19.The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of
                            myelodysplastic syndromes.
                        </a>
                        <span class='news_time'>Leukemia 1999;13:393–9.</span>
                        <span class='news_time'>Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki J-H, Iwama H, Inoue K, et al.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            19.The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of
                            myelodysplastic syndromes.
                        </a>
                        <span class='news_time'>Leukemia 1999;13:393–9.</span>
                        <span class='news_time'>Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki J-H, Iwama H, Inoue K, et al.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            20.Expression of the Wilms’ tumor gene WT1 in solid tumors and its involvement in tumor cell
                            growth.
                        </a>
                        <span class='news_time'>Jpn J Cancer Res 1999;90:194– 204.</span>
                        <span class='news_time'>Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            21.Overexpression of the Wilms’ tumor gene WT1 in primary astrocytic tumors.
                        </a>
                        <span class='news_time'>Cancer Sci 2004;95:822– 7.</span>
                        <span class='news_time'>Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            22.Overexpression of the Wilms’ tumor gene WT1 in head and neck squamous cell carcinoma.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:523– 9.</span>
                        <span class='news_time'>Oji Y, Inohara H, Nakazawa M, Nakano Y, Akahani S, Nakatusuka S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            23.Overexpression of the Wilms’ tumor gene WT1 in primary thyroid cancer.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:606–11.</span>
                        <span class='news_time'>Oji Y, Miyoshi Y, Koga S, Nakano Y, Ando A, Nakatuska S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            24.Overexpression of the Wilms’ tumor gene WT1 in esophageal cancer.
                        </a>
                        <span class='news_time'>Anticancer Res 2004;24:3103– 8.</span>
                        <span class='news_time'>Oji Y, Yano M, Nakano Y, Abeno S, Nakatsuka S, Ikeba A, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            25.Overexpression of the Wilms’ tumor gene WT1 in de novo lung cancers.
                        </a>
                        <span class='news_time'>Int J Cancer 2002;100:297– 303.</span>
                        <span class='news_time'>Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            26.Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumors despite
                            tumor-specific promoter methylation.
                        </a>
                        <span class='news_time'>Cancer Res 2001;61:921– 5.</span>
                        <span class='news_time'>Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            27.High expression of Wilms’ tumor suppressor gene (WT1) predicts poor prognosis in breast
                            cancer patients.
                        </a>
                        <span class='news_time'>Clin Cancer Res 2002;8:1167–71.</span>
                        <span class='news_time'>Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            28.Overexpression of the Wilms’ tumor gene WT1 in pancreatic ductal adenocarcinoma.
                        </a>
                        <span class='news_time'>Cancer Sci 2004;95:583–7.</span>
                        <span class='news_time'>Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            29.Overexpression of the Wilms’ tumor gene WT1 in colorectal adenocarcinoma.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:712–7.</span>
                        <span class='news_time'>Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            30.Overexpression of the Wilms’ tumor gene WT1 in human bone soft-tissue sarcomas.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:271– 6.</span>
                        <span class='news_time'>Ueda T, Oji Y, Naka N, Nakano Y, Takahashi E, Koga S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            31.Absence of mutations in the Wilms’ tumor gene WT1 in primary breast cancer.
                        </a>
                        <span class='news_time'>Jpn J Clin Oncol 2004;34:74 –7.</span>
                        <span class='news_time'>Oji Y, Miyoshi Y, Kiyotoh E, Koga S, Nakano Y, Ando A, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            32.Absence of mutations in the Wilms’ tumor gene wt1 in de novo non-small cell lung cancers.
                        </a>
                        <span class='news_time'>Neoplasma 2004;51:17 –20.</span>
                        <span class='news_time'>Oji Y, Miyoshi S, Takahashi E, Koga S, Nakano Y, Shintani Y, et al.</span>
                    </li>

                </ul>
            </div>

            <!--


            80. Tsuboi A, Oka Y, Nakajima H, Fukuda Y, Elisseeva OA, Yoshihara S, et al. Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma. Int J Hematol 2007;86:414–7.

74. Tsuboi A, Oka Y, Osaka T, Kumagai T, Tachibana I, Hayashi S, et al. WT1 peptide-based immunotherapy for patients with lung cancer. Microbiol Immunol 2004;48:175– 84.

90. Oji Y, Kitamura Y, Kamino E, Kitano A, Sawabata N, Inoue M, et al. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor. Int J Cancer 2009;125:381 –7.

72. Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, et al. Induction of WT1 (Wilms’ tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 2004;101:13885– 90.
86. Kawakami M, Oka Y, Tsuboi A, Harada Y, Elisseeva OA, Furukawa Y, et al. Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 microg/body) in a patient with chronic myelomonocytic leukemia. Int J Hematol 2007;85:426– 9.

84.Gillmore R, Xue SA, Holler A, Kaeda J, Hadjiminas D, Healy V, et al. Detection of Wilms’ tumor antigen – specific CTL in tumor-draining lymph nodes of patients with early breast cancer. Clin Cancer Res 2006;12:34– 42.

            -->

            <!--div class="index_contact">
            <h2 class="title_h2">联系我们</h2>
                <p style="padding-top:25px;">联系人：代码库</p>
                <p>手机：873468834</p>
                <p>电话：020-873468834</p>
                <p>邮箱：dmaku@163.com</p>
                <p>地址： 广东省广州市天河区天平架沙太路沙太路</p>
            </div-->
        </div>

    </div>
</div>

<nav class="navbar navbar-default navbar-fixed-bottom footer_nav">
    <div class="foot_nav btn-group dropup">
        <a class="dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"
           href="javascript:;">
            <span class="glyphicon glyphicon-share btn-lg" aria-hidden="true"></span>
            分享</a>
        <div class="dropdown-menu webshare">
            <!-- JiaThis Button BEGIN -->
            <div class="jiathis_style_32x32">
                <a class="jiathis_button_qzone"></a>
                <a class="jiathis_button_tsina"></a>
                <a class="jiathis_button_tqq"></a>
                <a class="jiathis_button_weixin"></a>
                <a class="jiathis_button_renren"></a>
                <a href="javascript:;" class="jiathis jiathis_txt jtico jtico_jiathis" target="_blank"></a>
            </div>
            <script type="text/javascript" src="js/jia.js" charset="utf-8"></script>
            <!-- JiaThis Button END -->            </div>
    </div>
    <div class="foot_nav"><a href="javascript:;"><span class="glyphicon glyphicon-phone btn-lg"
                                                       aria-hidden="true"></span>手机</a></div>
    <div class="foot_nav"><a id="gotocate" href="javascript:;"><span class="glyphicon glyphicon-th-list btn-lg"
                                                                     aria-hidden="true"></span>分类</a></div>
    <div class="foot_nav"><a id="gototop" href="javascript:;"><span class="glyphicon glyphicon-circle-arrow-up btn-lg"
                                                                    aria-hidden="true"></span>顶部</a></div>
</nav>

<footer>
    <div class="copyright">
        <p>CopyRight 2019 All Right Reserved 日本肿瘤研究院株式会社&nbsp; <a href="javascript:;" target="_blank">网站地图</a></p>
        <p class="copyright_p">本站的目的是XXXX&nbsp;</p>
    </div>

</footer>

<!--客服面板-->
<link rel="stylesheet" type="text/css" href="css/online.css"/>
<div id="cmsFloatPanel">
    <div class="ctrolPanel">
        <a class="service" href="javascript:;"></a>
        <a class="message" href="javascript:;"></a>
        <a class="qrcode" href="javascript:;"></a>
        <a class="arrow" title="返回顶部" href="javascript:;"></a>
    </div>
    <div class="servicePanel">
        <div class="servicePanel-inner">
            <div class="serviceMsgPanel">
                <div class="serviceMsgPanel-hd"><a href="javascript:;"><span>关闭</span></a></div>
                <div class="serviceMsgPanel-bd">
                    <!--在线QQ-->
                    <div class="msggroup">
                        <a target="_blank" href="javascript:;"><img class="qqimg"
                                                                    src="http://wpa.qq.com/pa?p=2:873468834:52"
                                                                    alt="QQ在线客服"/>技术支持</a>
                    </div>                          <!--在线MSN-->
                    <div class="msggroup">
                        <a href="javascript:;" target="blank"><img class="qqimg" src="images/msn.jpg" alt="MSN在线客服"/>
                            dmaku</a>
                    </div>                          <!--在线SKYPE-->
                    <div class="msggroup">
                        <a href="javascript:;"><img class="qqimg" src="images/skype.gif" alt="SKYPE在线客服"> dmaku</a>
                    </div>                          <!--淘宝旺旺-->
                    <div class="msggroup">
                        <a target=blank href="javascript:;"><img
                                SRC="http://amos.im.alisoft.com/online.aw?v=2&uid=代码库&site=cntaobao&s=1&charset=utf-8"
                                alt="点击联系我"></a>
                    </div>                          <!--旺旺国内版-->
                    <div class="msggroup">
                        <a target="_blank" href="javascript:;"><img
                                src="http://amos.alicdn.com/online.aw?v=2&uid=martin7752&site=cnalichn&s=10&charset=UTF-8"
                                alt="点击联系我"/></a>
                    </div>                          <!--旺旺国际版-->
                    <div class="msggroup">
                        <a class="alitalk-link" data-uid="alibabatest01" target="_blank" href="javascript:;"><img
                                class="qqimg"
                                src="http://amos.alicdn.com/online.aw?v=2&uid=alibabatest01&site=enaliint&s=22&charset=UTF-8"
                                alt="点击联系我"/> dmaku</a>
                    </div>
                </div>
                <div class="serviceMsgPanel-ft"></div>
            </div>
            <div class="arrowPanel">
                <div class="arrow02"></div>
            </div>
        </div>
    </div>
    <div class="messagePanel">
        <div class="messagePanel-inner">
            <div class="formPanel">

                <div class="formPanel-bd">
                    <!-- JiaThis Button BEGIN -->
                    <div class="jiathis_style_32x32">
                        <a class="jiathis_button_qzone"></a>
                        <a class="jiathis_button_tsina"></a>
                        <a class="jiathis_button_tqq"></a>
                        <a class="jiathis_button_weixin"></a>
                        <a class="jiathis_button_renren"></a>
                        <a href="javascript:;" class="jiathis jiathis_txt jtico jtico_jiathis" target="_blank"></a>
                    </div>
                    <script type="text/javascript" src="js/jia.js" charset="utf-8"></script>
                    <!-- JiaThis Button END --> <a type="button" class="btn btn-default btn-xs" href="javascript:;"
                                                   style="margin: 6px 0px 0px 10px;">关闭</a>
                </div>

            </div>
            <div class="arrowPanel">
                <div class="arrow01"></div>
                <div class="arrow02"></div>
            </div>
        </div>
    </div>
    <div class="qrcodePanel">
        <div class="qrcodePanel-inner">
            <div class="codePanel">
                <div class="codePanel-hd"><span style="float:left">用手机扫描二维码</span><a href="javascript:;"><span>关闭</span></a>
                </div>
                <div class="codePanel-bd">
                    <img src="images/529c3fcc09d41.jpg" alt="二维码"/>
                </div>
            </div>
            <div class="arrowPanel">
                <div class="arrow01"></div>
                <div class="arrow02"></div>
            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="js/online.js"></script>
</body>
</html>
<script type="text/javascript">
    var winHeight = 200;
    var timer = null;
    function show() {
        document.getElementById("popWin").style.display = "block";
        timer = setInterval("lift(5)", 2);
    }
    function hid() {
        timer = setInterval("lift(-5)", 2);
    }
    function lift(n) {
        var w = document.getElementById("popWin");
        var h = parseInt(w.style.height || w.currentStyle.height);
        if (h < winHeight && n > 0 || h > 1 && n < 0) {
            w.style.height = (h + n).toString() + "px";
        }
        else {
            w.style.display = (n > 0 ? "block" : "none");
            clearInterval(timer);
        }
    }
    window.onload = function () {
        setTimeout("show()", 1000);
    }
</script>

<!--

                          1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 1990;60:509–20.
                          2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990;343:774– 8.
                          3. Sugiyama H. Wilms’ tumor gene WT1: its oncogenic function and clinical application. Int J Hematol 2001;73:177– 87.
                          4. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. Isolation, characterization, and expression of the murine Wilms tumor gene (WT1) during kidney development. Mol Cell Biol 1991;11:1707– 12.
                          5. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, et al. The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet 1993;4:415–20.
                          6. Davies R, Moore A, Schedl A, Bratt E, Miyahawa K, Ladomery M, et al. Multiple roles for the Wilms’ tumor suppressor, WT1. Cancer Res 1999;59(Suppl 7):1747– 1750s; discussion 1751s.
                          7. Moore AW, Mclnnes L, Kreidberg J, Hastie ND, Schedl A. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999;126:1845–57.

                            8. Miwa H, Beran M, Aunders GF. Expression of the Wilms tumor gene (WT1) in human leukemias. Leukemia 1992;6:405 –9.
                            9. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I. Expression of the Candidate Wilms tumor gene, WT1, in human leukemia cells. Leukemia 1993;7:970 –7.
                            10. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as new prognostic factor a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994;84:3071–9.
                            11. Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, et al. High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997;90:1217– 25.
                            12. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L. The expression of the Wilms tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 1994;8:2138–43.
                            13. Menssen HD, Renkl H-J, Rodeck U, Maurer J, Notter M, Schwartz S, et al. Presence of Wilms tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995;9:1060–7.
                            14. Menssen HD, Renkl HJ, Rodeck U, Kari C, Schwartz S, Thiel E. Detection by monoclonal antibodies of the Wilms’ tumor (WT1) nuclear protein in patients with acute leukemia. Int J Cancer 1997;70:518–23.

15. Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002;16:2115– 21.
16. Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N, et al. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). Int J Hematol 2003;78:349– 56.
17. Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A, et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003;101:1698–704.
18. Greiner J, Ringhoffer M, Taniguchi M, Li L, Schmitt A, Shiku H, et al. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. Int J Cancer 2004;108:704– 11.
19. Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki J-H, Iwama H, Inoue K, et al. The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 1999;13:393–9.
20. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al. Expression of the Wilms’ tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 1999;90:194– 204.
21. Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T, et al. Overexpression of the Wilms’ tumor gene WT1 in primary astrocytic tumors. Cancer Sci 2004;95:822– 7.
22. Oji Y, Inohara H, Nakazawa M, Nakano Y, Akahani S, Nakatusuka S, et al. Overexpression of the Wilms’ tumor gene WT1 in head and neck squamous cell carcinoma. Cancer Sci 2003;94:523– 9.
23. Oji Y, Miyoshi Y, Koga S, Nakano Y, Ando A, Nakatuska S, et al. Overexpression of the Wilms’ tumor gene WT1 in primary thyroid cancer. Cancer Sci 2003;94:606–11.
24. Oji Y, Yano M, Nakano Y, Abeno S, Nakatsuka S, Ikeba A, et al. Overexpression of the Wilms’ tumor gene WT1 in esophageal cancer. Anticancer Res 2004;24:3103– 8.
25. Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, et al. Overexpression of the Wilms’ tumor gene WT1 in de novo lung cancers. Int J Cancer 2002;100:297– 303.
26. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al. Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 2001;61:921– 5.
27. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, et al. High expression of Wilms’ tumor suppressor gene (WT1) predicts poor prognosis in breast cancer patients. Clin Cancer Res 2002;8:1167–71.
28. Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, et al. Overexpression of the Wilms’ tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci 2004;95:583–7.
29. Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, et al. Overexpression of the Wilms’ tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 2003;94:712–7.
30. Ueda T, Oji Y, Naka N, Nakano Y, Takahashi E, Koga S, et al. Overexpression of the Wilms’ tumor gene WT1 in human bone soft-tissue sarcomas. Cancer Sci 2003;94:271– 6.
31. Oji Y, Miyoshi Y, Kiyotoh E, Koga S, Nakano Y, Ando A, et al. Absence of mutations in the Wilms’ tumor gene WT1 in primary breast cancer. Jpn J Clin Oncol 2004;34:74 –7.
32. Oji Y, Miyoshi S, Takahashi E, Koga S, Nakano Y, Shintani Y, et al. Absence of mutations in the Wilms’ tumor gene wt1 in de novo non-small cell lung cancers. Neoplasma 2004;51:17 –20.

-->
